The National Medical Products Administration (NMPA) oversees drug quality audits in China by setting standards, conducting inspections, and ensuring compliance with regulations. It evaluates manufacturing processes, verifies product safety and efficacy, and enforces corrective actions to maintain high-quality pharmaceutical products, safeguarding public health and fostering industry accountability.